CA1121738A - Automated intermittent blood purification process - Google Patents

Automated intermittent blood purification process

Info

Publication number: CA1121738A
Authority: CA; Canada
Prior art keywords: blood; dialysate; concentration; solute; hemodialysis
Prior art date: 1977-06-10
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Application number

CA000305132A

Other languages

English (en)

French (fr)

Inventor

William P. Murphy, Jr.

Frank A. Gotch

Bennie J. Lipps

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Althin Medical Inc

Original Assignee

Cordis Dow Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1977-06-10

Filing date

1978-06-09

Publication date

1982-04-13

1978-06-09 Application filed by Cordis Dow Corp filed Critical Cordis Dow Corp

1982-04-13 Application granted granted Critical

1982-04-13 Publication of CA1121738A publication Critical patent/CA1121738A/en

Status Expired legal-status Critical Current

Links

239000008280 blood Substances 0.000 title claims abstract description 145
210000004369 blood Anatomy 0.000 title claims abstract description 145
238000000746 purification Methods 0.000 title abstract description 6
238000001631 haemodialysis Methods 0.000 claims abstract description 65
230000000322 hemodialysis Effects 0.000 claims abstract description 65
210000003734 kidney Anatomy 0.000 claims abstract description 59
238000000502 dialysis Methods 0.000 claims description 53
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 25
238000004458 analytical method Methods 0.000 claims description 19
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 10
239000012528 membrane Substances 0.000 claims description 10
239000002699 waste material Substances 0.000 claims description 10
239000000203 mixture Substances 0.000 claims description 9
230000017531 blood circulation Effects 0.000 claims description 8
DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 claims description 8
239000012510 hollow fiber Substances 0.000 claims description 7
230000004044 response Effects 0.000 claims description 7
BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 claims description 5
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 5
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 5
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 5
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 5
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 5
239000011575 calcium Substances 0.000 claims description 5
229910052791 calcium Inorganic materials 0.000 claims description 5
239000001569 carbon dioxide Substances 0.000 claims description 5
229910002092 carbon dioxide Inorganic materials 0.000 claims description 5
230000000694 effects Effects 0.000 claims description 5
239000011777 magnesium Substances 0.000 claims description 5
229910052749 magnesium Inorganic materials 0.000 claims description 5
239000001301 oxygen Substances 0.000 claims description 5
229910052760 oxygen Inorganic materials 0.000 claims description 5
239000011591 potassium Substances 0.000 claims description 5
229910052700 potassium Inorganic materials 0.000 claims description 5
239000011734 sodium Substances 0.000 claims description 5
229910052708 sodium Inorganic materials 0.000 claims description 5
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 4
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 4
LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 claims description 4
TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 claims description 4
229940109239 creatinine Drugs 0.000 claims description 4
238000005086 pumping Methods 0.000 claims description 4
229940116269 uric acid Drugs 0.000 claims description 4
PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 claims description 2
238000000034 method Methods 0.000 abstract description 48
230000008569 process Effects 0.000 abstract description 40
238000011282 treatment Methods 0.000 abstract description 20
238000002360 preparation method Methods 0.000 abstract description 9
238000004159 blood analysis Methods 0.000 abstract description 3
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 17
239000011780 sodium chloride Substances 0.000 description 17
239000000306 component Substances 0.000 description 13
206010053567 Coagulopathies Diseases 0.000 description 11
230000035602 clotting Effects 0.000 description 11
239000003146 anticoagulant agent Substances 0.000 description 10
229940127219 anticoagulant drug Drugs 0.000 description 10
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 8
230000036772 blood pressure Effects 0.000 description 8
239000004202 carbamide Substances 0.000 description 6
150000002500 ions Chemical class 0.000 description 6
238000012545 processing Methods 0.000 description 5
208000001647 Renal Insufficiency Diseases 0.000 description 4
238000010276 construction Methods 0.000 description 4
230000006872 improvement Effects 0.000 description 4
238000001802 infusion Methods 0.000 description 4
230000037452 priming Effects 0.000 description 4
238000002560 therapeutic procedure Methods 0.000 description 4
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
238000006243 chemical reaction Methods 0.000 description 3
239000000701 coagulant Substances 0.000 description 3
238000011010 flushing procedure Methods 0.000 description 3
230000006870 function Effects 0.000 description 3
238000001727 in vivo Methods 0.000 description 3
201000006370 kidney failure Diseases 0.000 description 3
238000012423 maintenance Methods 0.000 description 3
230000008929 regeneration Effects 0.000 description 3
238000011069 regeneration method Methods 0.000 description 3
238000012360 testing method Methods 0.000 description 3
239000012503 blood component Substances 0.000 description 2
230000008859 change Effects 0.000 description 2
230000001684 chronic effect Effects 0.000 description 2
230000004087 circulation Effects 0.000 description 2
150000001875 compounds Chemical class 0.000 description 2
239000013256 coordination polymer Substances 0.000 description 2
235000005911 diet Nutrition 0.000 description 2
230000037213 diet Effects 0.000 description 2
239000007789 gas Substances 0.000 description 2
230000036541 health Effects 0.000 description 2
230000000977 initiatory effect Effects 0.000 description 2
230000010354 integration Effects 0.000 description 2
QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 2
229910052753 mercury Inorganic materials 0.000 description 2
108090000623 proteins and genes Proteins 0.000 description 2
102000004169 proteins and genes Human genes 0.000 description 2
239000000243 solution Substances 0.000 description 2
230000001954 sterilising effect Effects 0.000 description 2
239000000126 substance Substances 0.000 description 2
229940045136 urea Drugs 0.000 description 2
210000002700 urine Anatomy 0.000 description 2
210000003462 vein Anatomy 0.000 description 2
238000013022 venting Methods 0.000 description 2
PGOHTUIFYSHAQG-LJSDBVFPSA-N (2S)-6-amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-1-[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-4-methylsulfanylbutanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-3-sulfanylpropanoyl]amino]-4-methylsulfanylbutanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-hydroxybutanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-hydroxypropanoyl]amino]-3-hydroxypropanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-4-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-oxopentanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]-5-oxopentanoyl]amino]-3-phenylpropanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-4-oxobutanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-4-carboxybutanoyl]amino]-5-oxopentanoyl]amino]hexanoic acid Chemical compound CSCC[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(O)=O PGOHTUIFYSHAQG-LJSDBVFPSA-N 0.000 description 1
HLOFWGGVFLUZMZ-UHFFFAOYSA-N 4-hydroxy-4-(6-methoxynaphthalen-2-yl)butan-2-one Chemical compound C1=C(C(O)CC(C)=O)C=CC2=CC(OC)=CC=C21 HLOFWGGVFLUZMZ-UHFFFAOYSA-N 0.000 description 1
208000009304 Acute Kidney Injury Diseases 0.000 description 1
102000009027 Albumins Human genes 0.000 description 1
108010088751 Albumins Proteins 0.000 description 1
QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
241000726103 Atta Species 0.000 description 1
206010013082 Discomfort Diseases 0.000 description 1
HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
101100460205 Schizosaccharomyces pombe (strain 972 / ATCC 24843) new9 gene Proteins 0.000 description 1
241000193803 Therea Species 0.000 description 1
108010020828 Thrombofax Proteins 0.000 description 1
108010000499 Thromboplastin Proteins 0.000 description 1
102000002262 Thromboplastin Human genes 0.000 description 1
230000005856 abnormality Effects 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
230000001154 acute effect Effects 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
230000005540 biological transmission Effects 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
238000010241 blood sampling Methods 0.000 description 1
210000001124 body fluid Anatomy 0.000 description 1
239000010839 body fluid Substances 0.000 description 1
229920002678 cellulose Polymers 0.000 description 1
239000001913 cellulose Substances 0.000 description 1
239000003153 chemical reaction reagent Substances 0.000 description 1
208000020832 chronic kidney disease Diseases 0.000 description 1
239000002131 composite material Substances 0.000 description 1
238000012937 correction Methods 0.000 description 1
230000009089 cytolysis Effects 0.000 description 1
230000034994 death Effects 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
230000007812 deficiency Effects 0.000 description 1
230000000994 depressogenic effect Effects 0.000 description 1
238000010586 diagram Methods 0.000 description 1
235000020930 dietary requirements Nutrition 0.000 description 1
230000002996 emotional effect Effects 0.000 description 1
239000000835 fiber Substances 0.000 description 1
239000012530 fluid Substances 0.000 description 1
230000004907 flux Effects 0.000 description 1
230000037406 food intake Effects 0.000 description 1
-1 for example Substances 0.000 description 1
238000009472 formulation Methods 0.000 description 1
229960002897 heparin Drugs 0.000 description 1
229920000669 heparin Polymers 0.000 description 1
230000000266 injurious effect Effects 0.000 description 1
208000017169 kidney disease Diseases 0.000 description 1
230000003907 kidney function Effects 0.000 description 1
239000007788 liquid Substances 0.000 description 1
210000004880 lymph fluid Anatomy 0.000 description 1
206010025482 malaise Diseases 0.000 description 1
239000000463 material Substances 0.000 description 1
230000002503 metabolic effect Effects 0.000 description 1
239000002207 metabolite Substances 0.000 description 1
238000012544 monitoring process Methods 0.000 description 1
210000005036 nerve Anatomy 0.000 description 1
230000001453 nonthrombogenic effect Effects 0.000 description 1
230000000737 periodic effect Effects 0.000 description 1
230000002085 persistent effect Effects 0.000 description 1
230000006461 physiological response Effects 0.000 description 1
239000000700 radioactive tracer Substances 0.000 description 1
230000003134 recirculating effect Effects 0.000 description 1
230000009467 reduction Effects 0.000 description 1
238000011160 research Methods 0.000 description 1
238000012552 review Methods 0.000 description 1
238000005070 sampling Methods 0.000 description 1
238000004659 sterilization and disinfection Methods 0.000 description 1
239000002344 surface layer Substances 0.000 description 1
231100000331 toxic Toxicity 0.000 description 1
230000002588 toxic effect Effects 0.000 description 1
238000012546 transfer Methods 0.000 description 1
238000000108 ultra-filtration Methods 0.000 description 1
238000005303 weighing Methods 0.000 description 1

Classifications

- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/14—Ultrafiltration; Microfiltration
- B01D61/22—Controlling or regulating
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1601—Control or regulation
- A61M1/1603—Regulation parameters
- A61M1/1605—Physical characteristics of the dialysate fluid
- A61M1/1607—Physical characteristics of the dialysate fluid before use, i.e. upstream of dialyser
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1601—Control or regulation
- A61M1/1603—Regulation parameters
- A61M1/1605—Physical characteristics of the dialysate fluid
- A61M1/1609—Physical characteristics of the dialysate fluid after use, i.e. downstream of dialyser
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1601—Control or regulation
- A61M1/1603—Regulation parameters
- A61M1/1611—Weight of the patient
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1601—Control or regulation
- A61M1/1613—Profiling or modelling of patient or predicted treatment evolution or outcome
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1601—Control or regulation
- A61M1/1619—Sampled collection of used dialysate, i.e. obviating the need for recovery of whole dialysate quantity for post-dialysis analysis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1654—Dialysates therefor
- A61M1/1656—Apparatus for preparing dialysates
- A61M1/166—Heating
- A61M1/1662—Heating with heat exchange between fresh and used dialysate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1654—Dialysates therefor
- A61M1/1656—Apparatus for preparing dialysates
- A61M1/166—Heating
- A61M1/1664—Heating with temperature control
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
- A61M1/3403—Regulation parameters
- A61M1/341—Regulation parameters by measuring the filtrate rate or volume
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3607—Regulation parameters
- A61M1/3609—Physical characteristics of the blood, e.g. haematocrit, urea
- A61M1/361—Physical characteristics of the blood, e.g. haematocrit, urea before treatment
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3621—Extra-corporeal blood circuits
- A61M1/3643—Priming, rinsing before or after use
- A61M1/3644—Mode of operation
- A61M1/3646—Expelling the residual body fluid after use, e.g. back to the body
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1694—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes with recirculating dialysing liquid
- A61M1/1696—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes with recirculating dialysing liquid with dialysate regeneration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3621—Extra-corporeal blood circuits
- A61M1/3623—Means for actively controlling temperature of blood
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/12—General characteristics of the apparatus with interchangeable cassettes forming partially or totally the fluid circuit
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/30—Blood pressure

Landscapes

Health & Medical Sciences (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Engineering & Computer Science (AREA)
Vascular Medicine (AREA)
Hematology (AREA)
Public Health (AREA)
Biomedical Technology (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Anesthesiology (AREA)
Emergency Medicine (AREA)
Water Supply & Treatment (AREA)
Cardiology (AREA)
Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
External Artificial Organs (AREA)

CA000305132A 1977-06-10 1978-06-09 Automated intermittent blood purification process Expired CA1121738A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US80560077A	1977-06-10	1977-06-10
US805,600		1977-06-10

Publications (1)

Publication Number	Publication Date
CA1121738A true CA1121738A (en)	1982-04-13

Family

ID=25192005

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA000305132A Expired CA1121738A (en)	1977-06-10	1978-06-09	Automated intermittent blood purification process

Country Status (5)

Country	Link
JP (1)	JPS546397A (ja)
AU (1)	AU518734B2 (ja)
CA (1)	CA1121738A (ja)
DE (1)	DE2825134A1 (ja)
IT (1)	IT1105139B (ja)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ITMI20081247A1 (it) *	2008-07-09	2010-01-10	Gambro Lundia Ab	Apparato trattamento extracorporeo sangue
EP2896417A1 (en) *	2003-11-05	2015-07-22	Baxter International Inc.	Hemodialysis systems
US9884144B2 (en)	2003-11-05	2018-02-06	Baxter International Inc.	Hemodialysis system with cassette-based blood and dialysate pumping
US9950105B2 (en)	2007-02-09	2018-04-24	Baxter International Inc.	Blood treatment and electrical blood leak detection device therefore
US10130744B2 (en)	2012-09-21	2018-11-20	Gambro Lundia Ab	Apparatus and a method for extracorporeal blood treatment
US10463778B2 (en)	2007-02-09	2019-11-05	Baxter International Inc.	Blood treatment machine having electrical heartbeat analysis

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4370983A (en) *	1971-01-20	1983-02-01	Lichtenstein Eric Stefan	Computer-control medical care system
US4399036A (en) *	1979-06-14	1983-08-16	Diachem, Inc.	Proportioning system for bicarbonate dialysate
US4601830A (en) *	1979-11-19	1986-07-22	The United States Of America As Represented By The Administrator Of Veteran Affairs	Method for dialysis
FR2504816A1 (fr) *	1981-04-29	1982-11-05	Demandolx Philippe	Installation permettant le nettoyage et la sterilisation du dispositif echangeur d'un appareil de dialyse
WO1983004373A1 (fr) *	1982-06-11	1983-12-22	Ravet, Albert	Appareil pour l'hemodialyse sans anticoagulants
JPS61502942A (ja) *	1984-06-22	1986-12-18	ビ−チ、リチャ−ド・エル	改良された血液透析方法および血液透析溶液
SE465404B (sv) *	1988-03-03	1991-09-09	Gambro Ab	Dialyssystem
IT1252601B (it) *	1991-07-05	1995-06-19	Hospal Dasco Spa	Apparecchiatura e metodo di dialisi automatica
JP2846204B2 (ja) *	1993-01-11	1999-01-13	日機装株式会社	血液浄化装置およびこれを使用する中央監視システム
US5507723A (en) *	1994-05-24	1996-04-16	Baxter International, Inc.	Method and system for optimizing dialysis clearance
FR2767478B1 (fr) *	1997-08-21	1999-10-01	Hospal Ind	Dispositif et procede pour regler la concentration du sodium dans un liquide de dialyse en vue d'une prescription
EP1900384A1 (de) *	2006-09-15	2008-03-19	B. Braun Avitum AG	Therapieeinrichtung mit gedächtnisgestützter Regeleinrichtung
US8945936B2 (en)	2011-04-06	2015-02-03	Fresenius Medical Care Holdings, Inc.	Measuring chemical properties of a sample fluid in dialysis systems
CN115666677A (zh) *	2020-05-20	2023-01-31	尼普洛株式会社	血液循环监视方法、透析装置、以及程序

1978
- 1978-05-22 AU AU36320/78A patent/AU518734B2/en not_active Expired
- 1978-06-08 DE DE19782825134 patent/DE2825134A1/de not_active Withdrawn
- 1978-06-08 JP JP6930678A patent/JPS546397A/ja active Pending
- 1978-06-09 IT IT49795/78A patent/IT1105139B/it active
- 1978-06-09 CA CA000305132A patent/CA1121738A/en not_active Expired

Cited By (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US9884144B2 (en)	2003-11-05	2018-02-06	Baxter International Inc.	Hemodialysis system with cassette-based blood and dialysate pumping
US10293096B2 (en)	2003-11-05	2019-05-21	Baxter International Inc.	Dialysis system including cassette with pumping tubes
US11524103B2 (en)	2003-11-05	2022-12-13	Baxter International Inc.	Hemodiafiltration system with disposable pumping unit
EP2896417A1 (en) *	2003-11-05	2015-07-22	Baxter International Inc.	Hemodialysis systems
US9302039B2 (en)	2003-11-05	2016-04-05	Baxter International Inc.	Hemodialysis system including a disposable cassette
US9364602B2 (en)	2003-11-05	2016-06-14	Baxter International Inc.	Systems and methods for priming sorbent-based hemodialysis using dialysis fluid
US9387286B2 (en)	2003-11-05	2016-07-12	Baxter International Inc.	Dialysis system including peristaltic tubing pumping cassette
US9550020B2 (en)	2003-11-05	2017-01-24	Baxter International Inc.	Dialysis system with a varying rate ultrafiltration profile
US9572919B2 (en)	2003-11-05	2017-02-21	Baxter International Inc.	Dialysis system with cassette based balance chambers and volumetric pumps
US9642961B2 (en)	2003-11-05	2017-05-09	Baxter International Inc.	Renal failure therapy machines and methods including convective and diffusive clearance
US9675745B2 (en)	2003-11-05	2017-06-13	Baxter International Inc.	Dialysis systems including therapy prescription entries
US9872950B2 (en)	2003-11-05	2018-01-23	Baxter International Inc.	Renal therapy system having pump reversing fluid control
US10426883B2 (en)	2003-11-05	2019-10-01	Baxter International Inc.	Systems and methods for priming hemodialysis using multiple fluid sources
US10245369B2 (en)	2003-11-05	2019-04-02	Baxter International Inc.	Systems and methods for priming hemodialysis using dialysis fluid
US10245370B2 (en)	2003-11-05	2019-04-02	Baxter International Inc.	Renal failure therapy machines and methods including convective and diffusive clearance
US10155080B2 (en)	2003-11-05	2018-12-18	Baxter International Inc.	Renal therapy system with cassette-based blood and dialysate pumping
US10183109B2 (en)	2003-11-05	2019-01-22	Baxter International Inc.	Hemodialysis system including a disposable cassette
US12558466B2 (en)	2006-09-11	2026-02-24	Vantive Us Healthcare Llc	Hemodiafiltration system with disposable pumping unit
US10463778B2 (en)	2007-02-09	2019-11-05	Baxter International Inc.	Blood treatment machine having electrical heartbeat analysis
US9950105B2 (en)	2007-02-09	2018-04-24	Baxter International Inc.	Blood treatment and electrical blood leak detection device therefore
ITMI20081247A1 (it) *	2008-07-09	2010-01-10	Gambro Lundia Ab	Apparato trattamento extracorporeo sangue
WO2010004400A3 (en) *	2008-07-09	2010-02-25	Gambro Lundia Ab	An extracorporeal blood treatment apparatus
US8684959B2 (en)	2008-07-09	2014-04-01	Gambro Lundia Ab	Extracorporeal blood treatment apparatus
US10130744B2 (en)	2012-09-21	2018-11-20	Gambro Lundia Ab	Apparatus and a method for extracorporeal blood treatment
US11020518B2 (en)	2012-09-21	2021-06-01	Gambro Lundia Ab	Apparatus and a method for extracorporeal blood treatment

Also Published As

Publication number	Publication date
AU518734B2 (en)	1981-10-15
DE2825134A1 (de)	1978-12-21
JPS546397A (en)	1979-01-18
IT7849795A0 (it)	1978-06-09
IT1105139B (it)	1985-10-28
AU3632078A (en)	1979-11-29

Legal Events

Date	Code	Title	Description
1999-04-13	MKEX	Expiry

Publication	Publication Date	Title
EP0857074B2 (en)	2010-07-21	Hemodialysis monitoring system for hemodialysis machines
EP0847768B1 (en)	2001-09-19	Hemodialysis monitoring system for hemodialysis machines
EP0969887B1 (en)	2005-11-16	Hemofiltration system
EP1296727B1 (en)	2015-07-22	Apparatus for peripheral vein fluid removal in heart failure
RU2020970C1 (ru)	1994-10-15	Искусственная почка
US7399289B2 (en)	2008-07-15	Controller for ultrafiltration blood circuit which prevents hypotension by monitoring osmotic pressure in blood
US5902336A (en)	1999-05-11	Implantable device and method for removing fluids from the blood of a patient method for implanting such a device and method for treating a patient experiencing renal failure
US6217539B1 (en)	2001-04-17	Method of in-vivo determination of hemodialysis parameters and a device for carrying out the method
US4239041A (en)	1980-12-16	Method for continuous ambulatory peritoneal dialysis
CN100563729C (zh)	2009-12-02	血液治疗装置
EP1938847B1 (en)	2014-06-11	Apparatus for determining access flow
US20060009727A1 (en)	2006-01-12	Method and apparatus for an extracorporeal control of blood glucose
US20020068015A1 (en)	2002-06-06	Apparatus and method for control of ultrafiltration in extracorporeal treatment of blood
US20120298581A1 (en)	2012-11-29	Device and method for detecting an operating state of an extracorporeal blood treatment
WO1995032010A1 (en)	1995-11-30	Method and system for optimizing dialysis clearance
CA2276748A1 (en)	1998-07-16	Device and method for preparation of substitution solution
Zucchelli et al.	1978	Influence of ultrafiltration on plasma renin activity and adrenergic system
GB1601223A (en)	1981-10-28	Method and apparatus for continuous ambulatory peritoneal dialysis
David et al.	1995	Predilution hemofiltration. Clinical experience and removal of small molecular weight solutes
WO2025078443A1 (en)	2025-04-17	Extracorporeal blood treatment apparatus
WO2025078646A1 (en)	2025-04-17	Extracorporeal blood treatment apparatus
Emerson et al.	1995	Pitfalls of in vivo dialyzer clearance measurement
Wing et al.	1975	Haemodialysis: Principles and Equipment